Wall St Price Targets

OSSFF Price Forecast
Based on 8 analysts

+16% Upside
from $4.525 today

Embla Medical hf (OSSFF)’s 12-month stock price forecast through November 2027 has a consensus target of $5.256, implying 16% upside. The forecast is based on price targets from 8 Wall Street analysts.

OSSFF Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for OSSFF yet.

Embla Medical hf Competitors:
Price Targets

Financial Estimates

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is OSSFF's stock price target?
Price Target
5.256 USD

According to Wall Street analysts, the average 1-year price target for OSSFF is 5.256 USD with a low forecast of 4.635 USD and a high forecast of 5.918 USD.

What is the Revenue forecast for Embla Medical hf?
Projected CAGR
8%

Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 8 years is 8%.

What is the Gross Profit forecast for Embla Medical hf?
Projected CAGR
9%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 7%. The projected CAGR for the next 5 years is 9%.

What is the Operating Income forecast for Embla Medical hf?
Projected CAGR
11%

Over the last 13 years, the compound annual growth rate for Operating Income has been 6%. The projected CAGR for the next 8 years is 11%.

What is the Pre-Tax Income forecast for Embla Medical hf?
Projected CAGR
16%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 6%. The projected CAGR for the next 3 years is 16%.

What is the Net Income forecast for Embla Medical hf?
Projected CAGR
13%

Over the last 13 years, the compound annual growth rate for Net Income has been 6%. The projected CAGR for the next 5 years is 13%.

Back to Top